Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Addex Therapeutics stock | $8.51

Learn how to easily invest in Addex Therapeutics stock.

Addex Therapeutics Ltd is a biotechnology business based in the US. Addex Therapeutics shares (ADXN) are listed on the NASDAQ and all prices are listed in US Dollars. Addex Therapeutics employs 27 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Addex Therapeutics

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ADXN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

Addex Therapeutics stock price (NASDAQ: ADXN)

Use our graph to track the performance of ADXN stocks over time.

Addex Therapeutics shares at a glance

Information last updated 2021-10-10.
Latest market close$8.51
52-week range$8.88 - $17.98
50-day moving average $9.50
200-day moving average $9.89
Wall St. target priceN/A
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-2.73

Buy Addex Therapeutics shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Addex Therapeutics stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Addex Therapeutics price performance over time

Historical closes compared with the close of $8.51 from 2021-10-14

1 week (2021-10-08) -5.55%
1 month (2021-09-15) -12.36%
3 months (2021-07-15) -11.81%
6 months (2021-04-15) -16.98%
1 year (2020-10-15) -30.25%
2 years (2019-10-11) N/A
3 years (2018-10-11) N/A
5 years (2016-10-11) N/A

Addex Therapeutics financials

Revenue TTM $4 million
Gross profit TTM $-6,470,057
Return on assets TTM -35.4%
Return on equity TTM -72.5%
Profit margin 0%
Book value $2.89
Market capitalisation $51.5 million

TTM: trailing 12 months

Shorting Addex Therapeutics shares

There are currently 3,325 Addex Therapeutics shares held short by investors – that's known as Addex Therapeutics's "short interest". This figure is 11.6% down from 3,762 last month.

There are a few different ways that this level of interest in shorting Addex Therapeutics shares can be evaluated.

Addex Therapeutics's "short interest ratio" (SIR)

Addex Therapeutics's "short interest ratio" (SIR) is the quantity of Addex Therapeutics shares currently shorted divided by the average quantity of Addex Therapeutics shares traded daily (recently around 3392.8571428571). Addex Therapeutics's SIR currently stands at 0.98. In other words for every 100,000 Addex Therapeutics shares traded daily on the market, roughly 980 shares are currently held short.

However Addex Therapeutics's short interest can also be evaluated against the total number of Addex Therapeutics shares, or, against the total number of tradable Addex Therapeutics shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Addex Therapeutics's short interest could be expressed as 0% of the outstanding shares (for every 100,000 Addex Therapeutics shares in existence, roughly 0 shares are currently held short) or 0.0014% of the tradable shares (for every 100,000 tradable Addex Therapeutics shares, roughly 1 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Addex Therapeutics.

Find out more about how you can short Addex Therapeutics stock.

Addex Therapeutics share dividends

We're not expecting Addex Therapeutics to pay a dividend over the next 12 months.

Addex Therapeutics share price volatility

Over the last 12 months, Addex Therapeutics's shares have ranged in value from as little as $8.88 up to $17.98. A popular way to gauge a stock's volatility is its "beta".

ADXN.US volatility(beta: 1.46)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Addex Therapeutics's is 1.4586. This would suggest that Addex Therapeutics's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Addex Therapeutics overview

Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of oral small molecule allosteric modulators of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc. ; Indivior PLC; and The Charcot?Marie?Tooth Association. The company was formerly known as Addex Pharmaceuticals Ltd and changed its name to Addex Therapeutics Ltd in March 2012. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.

Frequently asked questions

What percentage of Addex Therapeutics is owned by institutions?
Currently 8.945% of Addex Therapeutics shares are held by institutions.
How many people work for Addex Therapeutics?
Latest data suggests 27 work at Addex Therapeutics.
When does the fiscal year end for Addex Therapeutics?
Addex Therapeutics's fiscal year ends in December.
Where is Addex Therapeutics based?
Addex Therapeutics's address is: Chemin des Mines, 9, Geneva, Switzerland, 1202
What is Addex Therapeutics's ISIN number?
Addex Therapeutics's international securities identification number is: US00654J1079
What is Addex Therapeutics's CUSIP number?
Addex Therapeutics's Committee on Uniform Securities Identification Procedures number is: 00654J107

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site